Doctor Nobutoyo Masunaga
Kyoto Medical Centre, Kyoto (Japan)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Year-to-year change of antithrombotic strategy and clinical outcomes of atrial fibrillation patients with vascular disease in this decade: The Fushimi AF Registry.
Event: ESC Congress 2023
Topic: Clinical
Session: From mobile health technology to clinical issues in atrial fibrillation
The association of left ventricular ejection fraction with incident heart failure in patients with atrial fibrillation
Event: ESC Congress 2022
Topic: Heart Failure in Atrial Fibrillation
Session: Interplay between heart failure and atrial fibrillation
Clinical characteristics and outcomes of atrial fibrillation patients with peripheral artery disease: The Fushimi AF Registry.
Event: ESC Congress 2022
Topic: Prevalence and Incidence of Atrial Fibrillation
Session: Atrial fibrillation and concomitant medical conditions
Comparison of characteristics and outcomes of atrial fibrillation patients undergoing coronary artery bypass grafting surgery and percutaneous coronary intervention: From the Fushimi AF Registry.
Event: ESC Congress 2017
Topic: Antiarrhythmic drugs
Session: Drug treatment
The clinical outcomes in atrial fibrillation patients with vascular disease: the Fushimi AF Registry.
Event: ESC Congress 2016
Topic: Atrial fibrillation (AF)
Session: Miscellaneous in arrhythmia
The combination therapy with oral anticoagulant and antiplatelet drug for atrial fibrillation patients: the Fushimi AF Registry.
Event: ESC Congress 2016
Topic: Atrial fibrillation (AF)
Session: Anticoagulation in atrial fibrillation II
ESC 365 is supported by
